The Significance and Implications of Nanotechnology in COVID-19
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide health hazard that has been classified as a pandemic by the World Health Organization (WHO). The task of developing efficient prevention and treatment measures for this p...
Saved in:
Published in | Research journal of pharmacy and technology Vol. 16; no. 5; pp. 2499 - 2506 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Raipur
A&V Publications
01.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide health hazard that has been classified as a pandemic by the World Health Organization (WHO). The task of developing efficient prevention and treatment measures for this pandemic is unparalleled. Due to nano-material's unique physicochemical features and controlled nano-bio interactions, nanotechnology has demonstrated significant potential in its capacity to combat a number of healthcare conditions. The application of nanotechnology for COVID-19 has been discussed in depth in this systematic review, which is divided into three sections: prevention, diagnostics, and treatment. To begin, we focused on nanotechnology-based protective equipment and disinfectants that can give much-needed protection against SARS-CoV-2. Again, nanoparticles can be used as an antigen carrier or adjuvant, paving the path for the development of a number of vaccines with preventive benefits. The capacity of nano-materials to magnify signal is then highlighted, which has been employed in the development of nano-biosensors and nano-imaging techniques that can be used for early-stage detection in conjunction with other diagnostic instruments. Finally, we discuss COVID-19 therapeutic approaches based on nano-materials. Nano-metals and their oxides affect cellular processes by interfering with the production of reactive oxygen species (ROS), which then give antiviral action. Various nano-products (polyethylenimine, squalene) can significantly lower the synthesis of inflammatory modulators (Cytokine storm), hence preventing Covid-19 infection. The review's limitations and nanoparticle's future directions for COVID-19 have been described briefly. This review is quite comprehensive and useful in terms of providing suggestions for developing nanomaterial-based devices to combat against COVID-19. |
---|---|
AbstractList | The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide health hazard that has been classified as a pandemic by the World Health Organization (WHO). The task of developing efficient prevention and treatment measures for this pandemic is unparalleled. Due to nano-material's unique physicochemical features and controlled nano-bio interactions, nanotechnology has demonstrated significant potential in its capacity to combat a number of healthcare conditions. The application of nanotechnology for COVID-19 has been discussed in depth in this systematic review, which is divided into three sections: prevention, diagnostics, and treatment. To begin, we focused on nanotechnology-based protective equipment and disinfectants that can give much-needed protection against SARS-CoV-2. Again, nanoparticles can be used as an antigen carrier or adjuvant, paving the path for the development of a number of vaccines with preventive benefits. The capacity of nano-materials to magnify signal is then highlighted, which has been employed in the development of nano-biosensors and nano-imaging techniques that can be used for early-stage detection in conjunction with other diagnostic instruments. Finally, we discuss COVID-19 therapeutic approaches based on nano-materials. Nano-metals and their oxides affect cellular processes by interfering with the production of reactive oxygen species (ROS), which then give antiviral action. Various nano-products (polyethylenimine, squalene) can significantly lower the synthesis of inflammatory modulators (Cytokine storm), hence preventing Covid-19 infection. The review's limitations and nanoparticle's future directions for COVID-19 have been described briefly. This review is quite comprehensive and useful in terms of providing suggestions for developing nanomaterial-based devices to combat against COVID-19. |
Author | Islam, Md. Jahirul Kumar Roy, Uthpall Chakraborty, Sangita Rahman, Mst. Mahfuza Md, Kouser Tasnim, Jarin Mohammad Shohan, Shahriar Shila, Mst. Shagorika Ibne Wahed, Mir Imam |
Author_xml | – sequence: 1 givenname: Mst. Mahfuza surname: Rahman fullname: Rahman, Mst. Mahfuza organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh – sequence: 2 givenname: Kouser surname: Md fullname: Md, Kouser organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh – sequence: 3 givenname: Uthpall surname: Kumar Roy fullname: Kumar Roy, Uthpall organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh – sequence: 4 givenname: Shahriar surname: Mohammad Shohan fullname: Mohammad Shohan, Shahriar organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh – sequence: 5 givenname: Jarin surname: Tasnim fullname: Tasnim, Jarin organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh – sequence: 6 givenname: Md. Jahirul surname: Islam fullname: Islam, Md. Jahirul organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh – sequence: 7 givenname: Mst. Shagorika surname: Shila fullname: Shila, Mst. Shagorika organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh – sequence: 8 givenname: Sangita surname: Chakraborty fullname: Chakraborty, Sangita organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh – sequence: 9 givenname: Mir Imam surname: Ibne Wahed fullname: Ibne Wahed, Mir Imam organization: Department of Pharmacy, University of Rajshahi, Rajshahi - 6205, Bangladesh |
BookMark | eNo9kEtrAjEUhUOxUGv9CYVA12PzmjxWpdiXIHVRW7oLyXijI5rYybjw33fU0rs59xwO98J3jXoxRUDolpJRyRSl98QoUXBJvkeMMD4iRFB6gfr_ce9_p_oKDXNek26kLpnQffQwXwH-qJexDnXlYgXYxQWebHebzrZ1ihmngN9dTC1Uq5g2aXnAdcTj2dfkqaDmBl0Gt8kw_NMB-nx5no_fiunsdTJ-nBYVFaItIFTey7DQCgj1glMQC_DMC6UNKKq0J4pob8Ar54yUwvMgtQQmiDEGJB-gu_PdXZN-9pBbu077JnYvLdOcCVUySrpWeW5VTcq5gWB3Tb11zcFSYk-47JGFPXKxR1z2hIv_AoMnXSs |
Cites_doi | 10.1016/j.tmaid.2020.101697 10.1007/s41204-021-00109-0 10.1186/s13287-020-01866-6 10.1016/j.nano.2019.03.004 10.1186/s13063-019-3846-x 10.1016/j.scitotenv.2020.142363 10.1007/s41204-021-00102-7 10.3390/nano10050852 10.1016/j.vaccine.2018.04.082 10.1016/j.nmni.2020.100679 10.1007/s13346-021-00911-y 10.1016/j.molimm.2017.09.001 10.1038/s41467-020-17317-y 10.1080/22221751.2020.1736644 10.3390/su12051841 10.1063/5.0043009 10.1038/s41565-020-0751-0 10.52711/2231-5691.2021.00042 10.1016/j.jtho.2020.02.010 10.1016/j.sintl.2020.100079 10.1021/acsnano.0c04421 10.1016/j.coelec.2020.08.011 10.3390/prosthesis3010005 10.2147/ijn.s241702 10.1016/j.sintl.2020.100046 10.2217/nnm-2018-0085 10.1038/nature03712 10.5958/0975-4377.2020.00037.3 10.4172/1745-7580-c3-021 10.1016/j.nantod.2021.101142 10.1186/s12929-019-0563-4 10.1021/jp801293a 10.1002/gch2.202000115 10.52711/2231-5691.2022.00008 10.1016/j.jbiosc.2020.01.008 10.1021/acsnano.0c05657 10.1186/s12951-020-00685-4 10.1128/jvi.78.12.6134-6142.2004 10.1016/j.sintl.2020.100038 10.5958/2231-5691.2020.00040.4 10.52711/2349-2996.2021.00117 10.1002/admi.201900622 10.3389/fchem.2020.00517 10.1021/acsnano.0c02823.s001 10.5958/2231-5713.2016.00019.2 10.1136/bmj.m3862 |
ContentType | Journal Article |
Copyright | Copyright A&V Publications May 2023 |
Copyright_xml | – notice: Copyright A&V Publications May 2023 |
DBID | AAYXX CITATION 04Q 04S 04W 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S PQEST PQQKQ PQUKI PRINS |
DOI | 10.52711/0974-360X.2023.00411 |
DatabaseName | CrossRef India Database India Database: Business India Database: Science & Technology ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China |
DatabaseTitle | CrossRef ProQuest Indian Journals ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Indian Journals: Business Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Indian Journals: Science & Technology ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | CrossRef ProQuest Indian Journals |
Database_xml | – sequence: 1 dbid: 7X7 name: Health & Medical Complete (ProQuest Database) url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 0974-360X 0974-306X |
EndPage | 2506 |
ExternalDocumentID | 10_52711_0974_360X_2023_00411 |
GroupedDBID | --- 04Q 04S 04W 3V. 7UP 7X7 8FI 8FJ AAYXX ABUWG ADBBV AFKRA AHMBA ALMA_UNASSIGNED_HOLDINGS BAI BAW BENPR BPHCQ BVXVI CCPQU CITATION FYUFA HMCUK IAO LXO MV. NFBOU NKUNM NXXTH NYMDV OK1 PQQKQ PROAC UKHRP ~ZZ 7XB 8FK K9. PQEST PQUKI PRINS |
ID | FETCH-LOGICAL-c144t-efcbb6fd87e01b431e4deb2b4789e7178b0708b9eb7aa9664b3f686e240999e63 |
IEDL.DBID | BENPR |
ISSN | 0974-3618 |
IngestDate | Thu Oct 10 19:50:31 EDT 2024 Fri Aug 23 02:42:40 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c144t-efcbb6fd87e01b431e4deb2b4789e7178b0708b9eb7aa9664b3f686e240999e63 |
PQID | 2832475210 |
PQPubID | 1096441 |
PageCount | 8 |
ParticipantIDs | proquest_journals_2832475210 crossref_primary_10_52711_0974_360X_2023_00411 |
PublicationCentury | 2000 |
PublicationDate | 2023-05-01 |
PublicationDateYYYYMMDD | 2023-05-01 |
PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Raipur |
PublicationPlace_xml | – name: Raipur |
PublicationTitle | Research journal of pharmacy and technology |
PublicationYear | 2023 |
Publisher | A&V Publications |
Publisher_xml | – name: A&V Publications |
References | ref13 ref12 ref15 ref14 ref11 ref10 ref17 ref16 ref19 ref18 ref51 ref50 ref46 ref45 ref48 ref47 ref42 ref41 ref44 ref43 ref49 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 ref35 ref34 ref37 ref36 ref31 ref30 ref33 ref32 ref0 ref2 ref1 ref39 ref38 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 |
References_xml | – ident: ref30 doi: 10.1016/j.tmaid.2020.101697 – ident: ref23 doi: 10.1007/s41204-021-00109-0 – ident: ref46 doi: 10.1186/s13287-020-01866-6 – ident: ref43 doi: 10.1016/j.nano.2019.03.004 – ident: ref15 doi: 10.1186/s13063-019-3846-x – ident: ref25 doi: 10.1016/j.scitotenv.2020.142363 – ident: ref28 doi: 10.1007/s41204-021-00102-7 – ident: ref19 doi: 10.3390/nano10050852 – ident: ref38 doi: 10.1016/j.vaccine.2018.04.082 – ident: ref4 doi: 10.1016/j.nmni.2020.100679 – ident: ref26 doi: 10.1007/s13346-021-00911-y – ident: ref35 doi: 10.1016/j.molimm.2017.09.001 – ident: ref11 – ident: ref17 – ident: ref6 doi: 10.1038/s41467-020-17317-y – ident: ref45 doi: 10.1080/22221751.2020.1736644 – ident: ref9 doi: 10.3390/su12051841 – ident: ref33 doi: 10.1063/5.0043009 – ident: ref29 doi: 10.1038/s41565-020-0751-0 – ident: ref1 doi: 10.52711/2231-5691.2021.00042 – ident: ref16 doi: 10.1016/j.jtho.2020.02.010 – ident: ref18 doi: 10.1016/j.sintl.2020.100079 – ident: ref24 doi: 10.1021/acsnano.0c04421 – ident: ref41 doi: 10.1016/j.coelec.2020.08.011 – ident: ref40 – ident: ref34 doi: 10.3390/prosthesis3010005 – ident: ref47 – ident: ref49 doi: 10.2147/ijn.s241702 – ident: ref13 doi: 10.1016/j.sintl.2020.100046 – ident: ref50 doi: 10.2217/nnm-2018-0085 – ident: ref31 doi: 10.1038/nature03712 – ident: ref7 doi: 10.5958/0975-4377.2020.00037.3 – ident: ref37 doi: 10.4172/1745-7580-c3-021 – ident: ref22 doi: 10.1016/j.nantod.2021.101142 – ident: ref48 doi: 10.1186/s12929-019-0563-4 – ident: ref44 doi: 10.1021/jp801293a – ident: ref20 doi: 10.1002/gch2.202000115 – ident: ref0 doi: 10.52711/2231-5691.2022.00008 – ident: ref32 doi: 10.1016/j.jbiosc.2020.01.008 – ident: ref39 doi: 10.1021/acsnano.0c05657 – ident: ref51 doi: 10.1186/s12951-020-00685-4 – ident: ref36 doi: 10.1128/jvi.78.12.6134-6142.2004 – ident: ref12 doi: 10.1016/j.sintl.2020.100038 – ident: ref21 – ident: ref3 doi: 10.5958/2231-5691.2020.00040.4 – ident: ref5 doi: 10.52711/2349-2996.2021.00117 – ident: ref27 doi: 10.1002/admi.201900622 – ident: ref8 doi: 10.3389/fchem.2020.00517 – ident: ref42 doi: 10.1021/acsnano.0c02823.s001 – ident: ref10 doi: 10.5958/2231-5713.2016.00019.2 – ident: ref2 doi: 10.1136/bmj.m3862 – ident: ref14 |
SSID | ssj0000685248 |
Score | 2.2840471 |
Snippet | The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide health hazard that has been... |
SourceID | proquest crossref |
SourceType | Aggregation Database |
StartPage | 2499 |
SubjectTerms | Drug delivery systems Nanomaterials Nanotechnology Pandemics Personal protective equipment |
Title | The Significance and Implications of Nanotechnology in COVID-19 |
URI | https://www.proquest.com/docview/2832475210 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1BT4MwFG7cdvFiNGqczqUHr90KlBZOi84tm4nTqDPcGgqt2QWmw__vK3TTXbwRSCB8H7zve49HH0I3aRqnoMsBoZppwsBgEDBHHLayzIAjN35q6x2PCz5bsockTFzBbePaKrcxsQ7UeZnZGvnQjtRhAsSGjtafxE6Nsl9X3QiNFur4kCnQNurcTRbPL7sqC-VR6NcjtCgYZxJwL2p-4wl94XlDt5MmAztFfGAXn_L2BWo_PteiMz1GR84t4tuG3hN0oItTNAJq8evqo7BdPpY0nBY5nv9pDcelwRA2y2pXN8erAo-f3uf3xIvP0HI6eRvPiJuDQDJIdyqiTaYUN3kkNPUUKL5mOSTEioko1pCORQre20jFWgmAnnOmAsMjrkGswf5pHpyjdlEW-gJhSHhzoCA04OxYrEycci_PBFyGaR3QvIsG25uX62a5CwlpQo2WtGhJi5a0aMkarS7qbSGS7unfyF-uLv8_fIUO7amaBsIealdf3_oaRL5SfdQSieg7Pn8A4emiDQ |
link.rule.ids | 315,783,787,12068,21400,27936,27937,31731,33756,43322,43817,74073,74630 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3BToNAEN1oPejFaNRYrboHr9tCWXbh1JhqQ7WtB1vDbcPCrukFqsX_dwZotRdvBBIIb2Dem2HYR8h9koQJ8LLHHMMN4yAwGIgjAVtpakGR236C_Y7pTEQL_hz7cdNwWzdjlZucWCXqrEixR95DSx0ugWycweqToWsUfl1tLDT2yQGuw4UOBjKW2x6LIwK_XxloOSCbmSfcoP6Jx-9L1-01O524ix7iXVx6yt2lp93sXFHO6IQcN1qRPtTBPSV7Jj8jAwgsfVt-5DjjgyGjSZ7R8Z_BcFpYCkmzKLddc7rM6fD1ffzI3PCcLEZP82HEGhcElkKxUzJjU62FzQJpHFcD3xueQTmsuQxCA8VYoOGtDXRotATgheDasyIQBqgaxJ8R3gVp5UVuLgmFcjeDAPgWdB0PtQ0T4WaphMtwYzwna5Pu5ubVql7sQkGRUKGlEC2FaClES1VotUlnA5Fqnv21-o3U1f-H78hhNJ9O1GQ8e7kmR3jaepSwQ1rl17e5Abov9W0V0x_8DaKx |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT4NAEJ1omxgvRqPGatU9eN0WyrLAqdF-pPWjNmpNbxsWdk0vUC3-f2dhW-3FG4EEwnvZeW-GWQbgJo6jGHXZo45iijI0GBTNEcejJNHoyHUnNvWOpwkfzdj93J_b_qeVbatcx8QyUKd5YmrkbTNShwW-2XGibVvEtD_sLj-pmSBlvrTacRq7UA8Y95wa1O8Gk-nLpuLi8NDvlOO0HDTR1ONuWG3p8TuB67btSWfeMhPFW-ZHVO62WG3H6lKAhodwYJ0jua2oPoIdlR1DF2kmr4uPzHT8GAJJnKVk_KdNnOSaYAjNi00NnSwy0nt-H_epG53AbDh4642onYlAE0x9Cqp0IiXXaRgox5Wo_oqlmBxLFoSRwtQslLiGQxkpGSANnDPpaR5yhcKNVlBx7xRqWZ6pMyCY_KZIh6_R5bFI6ijmbpoE-BimlOekDWitX14sq19fCEwZSrSEQUsYtIRBS5RoNaC5hkjYlbASv7yd_3_5GvaQUPE4njxcwL65a9VX2IRa8fWtLlH7C3llSf0Bk_KoTg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Significance+and+Implications+of+Nanotechnology+in+COVID-19&rft.jtitle=Research+journal+of+pharmacy+and+technology&rft.au=Rahman%2C+Mahfuza&rft.au=Kouser%2C+Md&rft.au=Roy%2C+Uthpall+Kumar&rft.au=Shohan%2C+Shahriar+Mohammad&rft.date=2023-05-01&rft.pub=A%26V+Publications&rft.issn=0974-3618&rft.eissn=0974-306X&rft.volume=16&rft.issue=5&rft.spage=2499&rft.epage=2506&rft_id=info:doi/10.52711%2F0974-360X.2023.00411&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0974-3618&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0974-3618&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0974-3618&client=summon |